> top > projects > sentences > docs > PubMed:1472759 > annotations
sentences Home  

PubMed:1472759 JSONTXT 62 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-186 Sentence denotes Alterations of glycosphingolipid-based blood group antigen expression on erythrocytes and in plasma studied on consecutive samples after a blood group O to A bone marrow transplantation.
T1 0-186 Sentence denotes Alterations of glycosphingolipid-based blood group antigen expression on erythrocytes and in plasma studied on consecutive samples after a blood group O to A bone marrow transplantation.
T1 0-186 Sentence denotes Alterations of glycosphingolipid-based blood group antigen expression on erythrocytes and in plasma studied on consecutive samples after a blood group O to A bone marrow transplantation.
TextSentencer_T2 187-325 Sentence denotes A blood group A1Le(a-b+) individual with chronic myeloid leukaemia had received a bone marrow graft from an HLA-identical OLe(a+b-) donor.
T2 187-325 Sentence denotes A blood group A1Le(a-b+) individual with chronic myeloid leukaemia had received a bone marrow graft from an HLA-identical OLe(a+b-) donor.
T2 187-325 Sentence denotes A blood group A1Le(a-b+) individual with chronic myeloid leukaemia had received a bone marrow graft from an HLA-identical OLe(a+b-) donor.
TextSentencer_T3 326-469 Sentence denotes Twelve months after bone marrow transplantation (BMT), the red blood cells of the patient became agglutinable with anti-A blood group reagents.
T3 326-469 Sentence denotes Twelve months after bone marrow transplantation (BMT), the red blood cells of the patient became agglutinable with anti-A blood group reagents.
T3 326-469 Sentence denotes Twelve months after bone marrow transplantation (BMT), the red blood cells of the patient became agglutinable with anti-A blood group reagents.
TextSentencer_T4 470-744 Sentence denotes To elucidate whether the blood group A antigen expression was of plasma or of bone marrow origin, total non-acid glycosphingolipid fractions were prepared from red blood cells and plasma collected 17 months after BMT, and from plasma collected 13, 15 and 19 weeks after BMT.
T4 470-744 Sentence denotes To elucidate whether the blood group A antigen expression was of plasma or of bone marrow origin, total non-acid glycosphingolipid fractions were prepared from red blood cells and plasma collected 17 months after BMT, and from plasma collected 13, 15 and 19 weeks after BMT.
T4 470-744 Sentence denotes To elucidate whether the blood group A antigen expression was of plasma or of bone marrow origin, total non-acid glycosphingolipid fractions were prepared from red blood cells and plasma collected 17 months after BMT, and from plasma collected 13, 15 and 19 weeks after BMT.
TextSentencer_T5 745-979 Sentence denotes The glycolipid fractions were analysed by thin-layer chromatography and immunostained with monoclonal A-antibodies, and permethylated and permethylated-reduced derivatives of selected plasma samples were analysed by mass spectrometry.
T5 745-979 Sentence denotes The glycolipid fractions were analysed by thin-layer chromatography and immunostained with monoclonal A-antibodies, and permethylated and permethylated-reduced derivatives of selected plasma samples were analysed by mass spectrometry.
T5 745-979 Sentence denotes The glycolipid fractions were analysed by thin-layer chromatography and immunostained with monoclonal A-antibodies, and permethylated and permethylated-reduced derivatives of selected plasma samples were analysed by mass spectrometry.
TextSentencer_T6 980-1082 Sentence denotes The results strongly indicate the presence of host bone marrow-produced blood group A red blood cells.
T6 980-1082 Sentence denotes The results strongly indicate the presence of host bone marrow-produced blood group A red blood cells.
T6 980-1082 Sentence denotes The results strongly indicate the presence of host bone marrow-produced blood group A red blood cells.
TextSentencer_T7 1083-1311 Sentence denotes Furthermore, the presence of a blood group H active pentaglycosylceramide type 1 (H-5-1) (Table I), characteristic for an OLe(a-b-) secretor, was seen in plasma 3-4 weeks before clinical chronic graft versus host disease (GVHD).
T7 1083-1311 Sentence denotes Furthermore, the presence of a blood group H active pentaglycosylceramide type 1 (H-5-1) (Table I), characteristic for an OLe(a-b-) secretor, was seen in plasma 3-4 weeks before clinical chronic graft versus host disease (GVHD).
T7 1083-1311 Sentence denotes Furthermore, the presence of a blood group H active pentaglycosylceramide type 1 (H-5-1) (Table I), characteristic for an OLe(a-b-) secretor, was seen in plasma 3-4 weeks before clinical chronic graft versus host disease (GVHD).
TextSentencer_T8 1312-1373 Sentence denotes After treatment of chronic GVHD, this expression disappeared.
T8 1312-1373 Sentence denotes After treatment of chronic GVHD, this expression disappeared.
T8 1312-1373 Sentence denotes After treatment of chronic GVHD, this expression disappeared.
TextSentencer_T9 1374-1505 Sentence denotes The blood group ALeb (A-7-1) antigen produced by the recipient seems to be present and to increase with time in all plasma samples.
T9 1374-1505 Sentence denotes The blood group ALeb (A-7-1) antigen produced by the recipient seems to be present and to increase with time in all plasma samples.
T9 1374-1505 Sentence denotes The blood group ALeb (A-7-1) antigen produced by the recipient seems to be present and to increase with time in all plasma samples.
TextSentencer_T10 1506-1568 Sentence denotes This also seems to be the case for the Leb and A-6-1 antigens.
T10 1506-1568 Sentence denotes This also seems to be the case for the Leb and A-6-1 antigens.
T10 1506-1568 Sentence denotes This also seems to be the case for the Leb and A-6-1 antigens.